State Ledger
Company profile

TENAX THERAPEUTICS, INC. CIK 34956

Ticker
TENX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Chapel Hill, NC 27517
Fiscal year end
2025 (FY)
Market Data
Close
$1.84
Change
-$0.04
Change %
-2.13%
Volume
71,886

TENX · trading date Oct 12, 2026 · previous close $1.88 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$52.60M
Total assets
$104.23M
Total liabilities
$7.16M
Stockholders' equity
$97.07M
Cash & equivalents
$97.60M
Operating income
-$56.39M
Operating cash flow
-$35.80M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
6.9%
Equity / assets
93.1%
CapEx / revenue
—
Operating cash flow / net income
0.68×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$52.60M $104.23M $7.16M $97.07M
2024 $0 -$17.60M $96.69M $4.69M $91.99M
2023 — -$7.71M $11.69M $3.59M $8.10M
2022 — $11.05M $3.40M $1.91M $1.49M
2021 — -$32.47M $5.99M $1.75M $4.24M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Chapel Hill, NC 27517
101 GLEN LENNOX DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:48 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to North Carolina — Public Companies